1. Pink Sheet
  2. >>Market Access

UnitedHealthcare Announces Zero Cost Sharing For Insulin As Legislative Relief Faces Challenges

 
• By Cathy Kelly

Private sector efforts to lower cost sharing for insulin continue but patient advocates and lawmakers still believe legislation is needed to tackle the issue in a comprehensive way.

Public Pressure Drives Private Payer Action But Is It Enough? • Source: Shutterstock

UnitedHealthcare is joining other national payers and pharmacy benefit managers in offering cost sharing relief for insulin in the private insurance market as US lawmakers work to move legislation capping copays at $35 per fill.

United's program will eliminate all cost sharing (copays and deductibles) for certain short- and long-acting insulins in the insurer’s standard fully insured group plans, the company announced 15 July

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access